EIF2S3

protein-coding

eukaryotic translation initiation factor 2 subunit gamma

Gene summary

The protein encoded by this gene is the largest subunit of a heterotrimeric GTP-binding protein involved in the recruitment of methionyl-tRNA(i) to the 40 S ribosomal subunit. [provided by RefSeq, Jan 2010]

Previous symbols:
  • EIF2G

MANE transcript

NM_001415.4

Inheritance

XL

ClinVar variants

P:10U:127B:17

Top phenotype

MEHMO syndrome

gnomAD constraint

pLI —, LoF o/e 0.07

Max pathogenic AF

—

Genomic locus

chrX:24,054,946-24,078,810

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~23.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

MEHMO syndromeSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010258

Submitter: PanelApp Australia

MEHMO syndromeSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010258

Submitter: Genomics England PanelApp

diabetes mellitusSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0005015

Submitter: Genomics England PanelApp

MEHMO syndromeSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010258

Submitter: G2P

MEHMO syndromeSUPPORTIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010258

Submitter: Orphanet

MEHMO syndromeSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010258

Submitter: Labcorp Genetics (formerly Invitae)

MEHMO syndromeDEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010258

Submitter: ClinGen

The *EIF2S3* gene encodes the γ subunit of eukaryotic translation initiation factor-2 (eIF2), a heterotrimeric GTP-binding protein involved in the recruitment of methionyl-tRNA(i) to the 40S ribosomal subunit. The acronym MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity) was coined by Steinmuller et al. (PMID: 9781023) who described a large three-generation family with five affected boys and mapped the disease locus to the short arm of chromosome X. Using chromosome X-exome sequencing, Skopkova et al. (2017) identified a frameshift mutation, I465Sfs, in *EIF2S3* in an affected male in the family reported by Steinmüller et al. (1998). Functional assays using a yeast/human (Sc/Hs) chimeric form of eIF2γ in yeast demonstrated the variant impairs eIF2γ function. The same variant was also detected in other 3 unrelated families with typical MEHMO syndrome features in affected males. Sequencing data suggested a founder effect for this variant (PMIDs: 27333055, 28055140, 29303605). Five missense mutations, which exhibited reduced growth rate and/or impaired translation function in yeast, were also reported in male patients exhibiting either typical features of MEHMO or milder phenotypes with a subset of MEHMO features, supporting variable clinical expressivity of MEHMO in patients with deleterious *EIF2S3* variants (PMIDs: 23063529, 27333055, 30878599, 32799315). The association is seen in 14 probands in 6 publications (PMID: 27333055, 28055140, 23063529, 29303605, 30878599, 32799315). The mechanism for disease is expected to be hemizygous loss of function. All reported female carriers are asymptomatic. Morpholino-based knockdown of the zebrafish *EIF2S3* ortholog recapitulates the human microcephaly and short stature phenotype (PMID: 27333055). An *EIF2S3* knockdown human pancreatic β cell line showed impaired cell survival and increased caspase activities (PMID: 30878599). In summary, the *EIF2S3*/MEHMO syndrome gene-disease relationship is definitive. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 11, 2021 (SOP version 8).

Clinical Genomic Database (CGD)

MEHMO syndromeXL

Manifestation: Craniofacial; Endocrine; Musculoskeletal; Neurologic

Intervention: Endocrine

Rationale: Awareness of endocrine manifestations, including growth hormone deficiency and hypogonadism, may allow early recognition and treatment

Refs: 23063529; 27333055; 28055140Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to EIF2S3 variants in ClinVar

6 Conditions Cataloged
not providedTotal: 51
MEHMO syndromeTotal: 20
not specifiedTotal: 13
Inborn genetic diseasesTotal: 13
EIF2S3-related disorderTotal: 5
Intellectual disabilityTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001415.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
17
clinvar
14
clinvar
2
clinvar
33
missense
3
clinvar
6
clinvar
74
clinvar
1
clinvar
84
nonsense
4
clinvar
4
start loss
0
frameshift
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
31
clinvar
31
Total37127152154
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 33 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001415.4RefSeqNP_001406.112MANE Select
ENST00000253039.9EnsemblENSP00000253039.412MANE Select
ENST00000423068.1EnsemblENSP00000391383.15Standard
ENST00000864815.1EnsemblENSP00000534874.112Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
eif2s3Danio rerio

Structure: trunk

Quality: necrotic

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • RNA transport - Homo sapiens (human)
  • Translation Factors
  • double stranded rna induced gene expression
  • skeletal muscle hypertrophy is regulated via akt-mtor pathway
  • Formation of the ternary complex, and subsequently, the 43S complex

Biological Process

  • formation of translation preinitiation complex
  • translational initiation
  • transmembrane transport

Molecular Function

  • translation initiation factor activity
  • GTPase activity
  • protein binding
  • GTP binding
  • translation factor activity, RNA binding

Cellular Component

  • nucleus
  • cytoplasm
  • cytosol
  • eukaryotic translation initiation factor 2 complex
  • extracellular exosome

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000253039
Coding exons
12
Length
23256
Individuals with no LoFs
125716
Homozygous LoFs
0
Heterozygous LoFs
21
Defined
125737
p
0.0000835
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense3.61421770.2370.00001303052
Missense (PolyPhen)044.2170855
Synonymous-0.1306361.71.020.00000462944
Loss of Function3.32114.70.06780.00000100295

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000320.00025rare
Latino/Admixed American0.0000810.000058rare
Ashkenazi Jewish0.000140.000099rare
East Asian00.0absent
Finnish0.000190.00014rare
European (Non-Finnish)0.000130.000088rare
South Asian00.0absent
Other0.000240.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: As a subunit of eukaryotic initiation factor 2 (eIF2), involved in the early steps of protein synthesis. In the presence of GTP, eIF2 forms a ternary complex with initiator tRNA Met-tRNAi and then recruits the 40S ribosomal complex, a step that determines the rate of protein translation. This step is followed by mRNA binding to form the 43S pre-initiation complex. Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF2 and release of an eIF2-GDP binary complex. In order for eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP by way of a reaction catalyzed by eIF2B (By similarity). Along with its paralog on chromosome Y, may contribute to spermatogenesis up to the round spermatid stage (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q9Z0N1}.;

Recessive Scores

pRec
0.218

Intolerance Scores

LoFtool
0.117
RVIS EVS
0.13
RVIS percentile EVS
62.74

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.973

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.